Flores, Mary Jane P.

HRN: 27-33-70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2025
CEFUROXIME 750MG (VIAL)
06/15/2025
06/22/2025
IV
750 Mg
Q8
Snake Bite
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines